Adaptive Biotechnologies (ADPT) Other Accumulated Expenses (2018 - 2025)

Adaptive Biotechnologies has disclosed Other Accumulated Expenses across 8 years of filings, most recently posting $826000.0 for Q4 2025.

• Other Accumulated Expenses for Q4 2025 came in at $826000.0, changed 0.48% year-over-year; the trailing twelve-month figure through Dec 2025 was $826000.0 (changed 0.48% YoY), and the FY2025 annual result was $826000.0, changed 0.48% from the prior year.
• Other Accumulated Expenses came in at $826000.0 for Q4 2025 at Adaptive Biotechnologies, roughly flat from $830000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.7 million in Q4 2022 to a low of $763000.0 in Q4 2023.
• The 5-year median for Other Accumulated Expenses is $830000.0 (2024), against an average of $1.0 million.
• Across the five-year window, Other Accumulated Expenses soared 58.52% in 2022 and tumbled 53.9% in 2023, its largest moves.
• Adaptive Biotechnologies' Other Accumulated Expenses stood at $1.0 million in 2021, then jumped by 58.52% to $1.7 million in 2022, then sank by 53.9% to $763000.0 in 2023, then increased by 8.78% to $830000.0 in 2024, then retreated by 0.48% to $826000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $826000.0 (Q4 2025), $830000.0 (Q4 2024), and $763000.0 (Q4 2023), per Business Quant data.